Biobot Analytics Raises $20M Series A to Expand Its Wastewater Epidemiology Data Platform

Cambridge, Mass. – October 22, 2021 – Biobot Analytics,  the company who rapidly scaled their wastewater monitoring and detection platform in response to Covid-19, announces today 20M in Series A funding. The pandemic underscored a need for continuous, reliable population health data so that public officials can make decisions to protect those in their community […]

Biobot Analytics Demonstrates the Utility of Wastewater Sequencing As a Powerful Tool in the Fight Against COVID-19 Variants

Cambridge, Mass. – September 9th, 2021 – Biobot Analytics, in collaboration with Ginkgo Bioworks, today announced a successful campaign to sequence over 2,000 wastewater samples across all 50 states for SARS-CoV-2. This groundbreaking research and development effort, initiated as a part of the Department of Health and Human Services’ (HHS) national wastewater-based disease monitoring program, […]

Biobot Analytics Adds William Hanage as Scientific Advisor

Dr. Hanage is a Leader in the Evolution and Epidemiology of Infectious Disease Cambridge, Mass. – June 28, 2021 – Biobot Analytics, a leader in wastewater epidemiology,today announced that William Hanage, Associate Professor of Epidemiology at Harvard T.H. ChanSchool of Public Health, is joining the company as Scientific Advisor. “Dr. Hanage’s expertise and hands-on experience […]

U.S. Dept. of Health and Human Services Selects Biobot to Establish a National Wastewater-based Disease Monitoring Program

Cambridge, MA. – May 25, 2021 – The U.S. Department of Health & Human Services hasselected Biobot Analytics to establish a national disease surveillance program, leveragingwastewater epidemiology. In a twelve-week program, HHS will fund the collection and analysis ofsamples from 320 wastewater treatment plants, covering 100 million people across 50 states andterritories, to gather data […]

Honorable Andrew C. Weber Joins Biobot Analytics’ Board of Advisors

Andrew Weber, Senior Fellow

Mr. Weber is a Leader in Strengthening Global Health Security Cambridge, Mass. – May 4, 2021 – Biobot Analytics, a leader in wastewater epidemiology, todayannounced that Andrew Weber, a Senior Fellow at The Council on Strategic Risks, has joined thecompany’s newly-formed Board of Advisors. “Mr. Weber’s decades of experience and leadership in global health security […]

Biobot Analytics Launches Board of Advisors with Dr. John Brownstein as First Member

John Brownstein, CIO

Dr. Brownstein is a Leader in Public Health and Epidemiology Cambridge, Mass. – April 20th, 2021 – Biobot Analytics, leader in wastewater epidemiology,today announced that Dr. John Brownstein, Chief Innovation Officer of Boston Children’s Hospitaland Professor of Biomedical Informatics at Harvard Medical School, has joined the company’snewly-formed Board of Advisors. “Dr. Brownstein’s participation on our […]

Biobot Analytics, SMART Achieve COVID-19 Variant Detection

Wastewater analysis can now be used to identify the B.1.1.7 variant of SARS-CoV-2 Cambridge, Mass. – March 31st, 2021 – In a scientific breakthrough, researchers havesuccessfully detected the B.1.1.7 variant of SARS-CoV-2, the virus that causes COVID-19, inwastewater samples across the United States. B.1.1.7 was first identified in the United Kingdom and is commonly referred […]

Biobot Analytics again hailed for leadership in applying wastewater analytics to COVID-19

Government Technology Magazine Names Biobot as Top 100 Company in Government Technology Cambridge, Mass. — January 5, 2021 — In another recognition of Biobot Analytics’ leadership using wastewater epidemiology in the fight against COVID, Government Technology magazine has named Biobot Analytics as a GovTech 100 company for 2021. Biobot Analytics, based in Cambridge, Mass., is […]